Altamira Therapeutics Ltd. Key Management Personnel Compensation Share-based Payment
Altamira Therapeutics Ltd. (CYTOF) reported Key Management Personnel Compensation Share-based Payment of $302.50 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment · last filed 2025-04-30
CHF
| Period end | Key Management Personnel Compensation Share-based Payment 12 month |
|---|---|
| 2023-12-31 | 283.59K CHF 20-F/A · filed 2024-04-22 |
| 2022-12-31 | 223.29K CHF 20-F/A · filed 2024-04-22 |
| 2021-12-31 | 240.41K CHF 20-F/A · filed 2024-04-22 |
| 2020-12-31 | 261.99K CHF 20-F · filed 2023-05-16 |
| 2019-12-31 | 159.24K CHF 20-F · filed 2022-04-12 |
| 2018-12-31 | 264.88K CHF 20-F · filed 2021-03-31 |
| 2017-12-31 | 263.31K CHF 20-F · filed 2020-04-16 |
| 2016-12-31 | 321.36K CHF 20-F · filed 2019-03-14 |
| 2015-12-31 | 237.71K CHF 20-F · filed 2018-03-22 |
USD
| Period end | Key Management Personnel Compensation Share-based Payment 12 month |
|---|---|
| 2024-12-31 | $302.50K 20-F · filed 2025-04-30 |
| 2023-12-31 | $315.62K 20-F · filed 2025-04-30 |
| 2022-12-31 | $233.81K 20-F · filed 2025-04-30 |